|
|
Greetings!
Welcome to Families First, the Child Neurology Foundation (CNF) e-newsletter for parents and caregivers of children living with neurologic conditions. We trust you and your loved ones created wonderful memories this summer and have had a successful start to the school year!
This quarter, we are so excited to introduce a new CNF initiative developed in honor of you: the parent and caregiver Heroes of child neurology. The CNF Board of Directors, a group of the nation's leading child neurologists and parent advoactes, has established a new annual parent advocacy award that will recognize the critical role parents and caregivers play in the provision of quality care to children with neurologic conditions: The John and Laurian Scott Hero of Promise Award. We will honor the award's namesakes with the inaugural award on Saturday, November 8, 2014 at the Child Neurology Foundation's first annual Los Angeles gala, A Heroes Dinner.
In this issue, we will provide information and resources on BVVL, a rare neuromuscular disease that took the lives of two of the Scott's children (most of these resources were created or complied by the Scotts themselves!). We will highlight the promise they fulfilled to their son and daughter by working with researchers to identify the gene that causes the disease, a feat that has allowed them to have healthy twins and provide the same opportunity for other families! By the end of this newsletter, we are certain you will understand why John and Laurian Scott served as the inspiration for the Hero of Promise Award and trust you will want to join us in celebrating your fellow child neurology Heroes by participating in A Heroes Dinner by attending, donating, or sponsoring a dedication ad in our tribute journal in honor of a child neurology hero that you know.
|
|
 |
|
WHAT IS BROWN-VIALETTO-VAN LAERE (BVVL) SYNDROME?
BVVL is a rare, progressive, neurodegenerative motor neuron disorder that specifically includes palsies (paralysis) of the cranial nerves, and is sometimes referred to as "bulbar palsy."
The name Brown-Vialetto-Van Laere comes from physicians and researchers who described some of the first reported cases (Brown, 1894; Vialetto, 1936; and Van Laere, 1966), all of which also include sensorineural hearing loss. Though sensorineural hearing loss is a primary component of the syndrome, it may not be discovered until late in children due to the mildness of the hearing loss or the more obvious symptoms that manifest first. Progressive bulbar palsy without hearing loss is referred to as Fazio-Londe syndrome.
Onset of symptoms varies from infancy to the third decade. In many cases, children lead a normal life developmentally, disease-free, for years before developing symptoms. Typically, the first symptom is sensorineural deafness. Other examples of nerve degeneration include vocal cord paralysis, ptosis (droopy eyelids), facial weakness, slurred speech, dysphagia (difficulty swallowing), visual difficulty secondary to optic atrophy, neck and shoulder weakness, limb weakness, autonomic dysfunction, and respiratory compromise.
The course of the disease is variable. Until 2010, when a potential therapy (intravenous B2/riboflavin) was attempted after the gene was discovered, some affected individuals gradually got worse while others had plateaus of stable disease throughout their course; however, all cases up to that point had been fatal, with only one-third of all individuals affected with Brown-Vialetto-Van Laere surviving for longer than ten years.
In 2010, the first gene for BVVL was discovered, elucidating the disease as a possible riboflavin transporter gene mutation. Since then, other genes have been discovered with similar malfunction. In the same year, trial therapy with B2/riboflavin was attempted for the first time, proving to be a potent stabilizer of disease for many patients with the disease.
What is the cause of BVVL?
BVVL is now linked to several genes that cause riboflavin transport deficiency. Several researchers continue to study the exact mechanism, including the creation of a mouse model so that we can better understand the exact reason for the disease. Most genes appear to have an autosomal recessive pattern of inheritance. Gene testing is currently available for any patient suspected of having the disease through Dr. Henry Houlden's lab in the United Kingdom.
How common is BVVL?
Throughout the past century, less than 100 cases of Brown-Vialetto-Van Laere have been reported in the literature from families around the world, although those numbers are growing.
Through the BVVL International website
(read more about BVVL International to the right), families and/or their physicians are reporting their diagnoses, and we are learning that BVVL is not near as rare as the literature suggests.
How is BVVL diagnosed?
Clinical presentation of hearing loss, other cranial nerve palsies, and lower motor neuron limb involvement raises the possibility of BVVL. However, it is important to be evaluated by a pediatric neurologist who can also test for treatable metabolic conditions which may present similarly. It is also important to seek a second opinion.
Hearing tests show sensorineural hearing loss, and brainstem auditory evoked potentials (BAER) are abnormal. Magnetic resonance imaging (MRI) of the brain may show hyperintensities, especially in the brainstem, or may show nothing at all. Muscle biopsy results are typically normal or show groups of atrophic fibers suggesting denervation of muscles. Neurophysiologic tests such as EMG and nerve conduction studies also confirm denervation of muscles, both chronic and active. Cerebral spinal fluid (CSF) analysis after lumbar puncture is typical normal or only shows mildly elevated protein.
Although BVVL shares similar features with a family of diseases known as spinal muscular atrophy (SMA), affected individuals that have been tested and reported in the literature were negative for SMA gene mutations.
Any patient suspected of having BVVL should be tested immediately for one of the BVVL genes, the known riboflavin transporter gene mutations. For BVVL genetic testing, please visit http://www.ncbi.nlm.nih.g
ov/sites/GeneTests/?db=GeneTests, under BVVLS, where the details of the lab and services they offer can be found.
However, it is important NOT TO WAIT FOR THOSE RESULTS before starting trial intravenous B2/riboflavin therapy with your doctor if BVVL is strongly suspected. Patients who are treated early in the disease have shown more clinical improvement.
Is there treatment?
There is no certain effective treatment for Brown-Vialetto-Van Laere; however, there have been reports of stabilization or reversal of degeneration with the use of a new B2 Protocol. However, this therapy does not appear to work for all patients. This is a future area of research, why some patients respond to B2 and why some do not.
For further information and instruction on the informal study of Riboflavin therapy, please contact one of the authors, Dr. Bosch, at the University of Amsterdam at a.m.bosch@amc.nl.
In some past case reports which are less promising, steroids and intravenous immunoglobulins (IVIg) have been tried with little success, typically short periods of stabilization before disease progression.
Supportive care and symptomatic treatment such as tracheostomy, assisted ventilation, and gastrostomy are typically offered to patients and their families when therapy is not working.
|
|
ADVOCACY
Proceeds from
A Heroes Dinner will be dedicated to CNF's ongoing mission in action as well as the establishment of an annual Foundation Award offering early support to a rising star in child neurology who is committed to research in childhood neurological disease-etiology, treatment, and health care policy-that will serve to improve the lives of our children and their families.
If you would like to contribute to advancements in treatments and cures for BVVL and the over 400 pediatric neurologic diseases that affect one-in-four children in the U.S., please see the form to the right to learn how you or someone you know can attend and/or sponsor A Heroes Dinner.
Help us honor the promise John and Laurian Scott made to their late children and make a promise to yourself. A promise to show up when the unthinkable happens. A promise to say never again. A promise to be the Hero that lingers within. After all, our children deserve to see Heroes every day.
|
Stay Connected

|
|
|
|
|
|
The John and Laurian Scott Hero of Promise Award
We've come to think of Heroes as imaginary creatures, somehow separate from our daily reality. Yet our humanity beckons us to believe we can battle against the unjust problems of today and win.
In essence, we beg for the arrival of Heroes.
One-in-four children in the United States lives with a neurologic disease - ranging from Autism and Epilepsy to rare neuromuscular diagnoses. These 18 million affected children, and their families, are asked daily to be their own Heroes; and, in doing so, they have become ours.
John and Laurian Scott know the reality of caring for a child living with neurologic disease. Their daughter Thisbe began showing signs of a rare neuromuscular disorder, Brow-Vialetto-Van Laere (BVVL) when she was 16-months. It was a disease that robbed her body the joys of being a little girl, making her dependent on machines to eat and breathe. Just shy of her third birthday, Thisbe took her last breath; and her parents promised never again. But again came too soon as their younger son Noah began to show symptoms of the same disorder just one month later. This unthinkable nightmare continued with Noah's death a year after his sister's.
Two children. One promise. In the years following, John and Laurian worked toward fulfilling their promise; and, in 2011, it was realized when the gene causing this deadly disease was identified. This research feat subsequently allowed them to have two healthy children and set forth this same possibility for future families. In addition, they have worked tirelessly to raise funds and provide information, resources, and support previously unavailable to families affected not only by BVVL but all pediatric neuromuscular disorders. Please read more about John and Laurian's heroic efforts in the articles below and you will see...
Heroes didn't have to show up for John and Laurian; they simply stood up. And they aren't alone. To celebrate the Heroes that care for children afflicted with neurologic disease, the CNF is hosting A Heroes Dinner on Saturday, November 8, 2014 at The Four Seasons - Beverly Hills. This evening reception will announce the establishment of The John & Laurian Scott - Hero of Promise Award. It is an award that begs us to not only honor the promise they made to their late children but to make one to ourselves. A promise to show up when the unthinkable happens. A promise to say never again. A promise to be the Hero that lingers within. After all, our children deserve to see Heroes every day.
Please CLICK HERE or scroll to the bottom of this newsletter to learn how you can be part of A Heroes Dinner.
|
 |
|
TWO CHILDREN. ONE DISEASE.
THEIR VOICES INSPIRE THOUSANDS. MAY THEIR LEGACY CURE MILLIONS. 
The Scott Story, as told by Laurian Scott
We will never get over the loss of our daughter and our son, and their suffering is something we will equally never be able to reconcile. For those of you who have supported and loved us while we traveled this road, we are forever grateful. For those of you just learning about the Thisbe and Noah Scott Foundation, this is our story:
Elenna "Thisbe" Scott would have been ten on July 11, 2014. She was healthy the first 16 months of her life and sick beyond all comprehension the last 17 months. It took five very long months to get a diagnosis. Nearly every pediatric neurologist from UCLA to Stanford and Boston Children's to the NIH could only tell us, "I've never heard of it." Even the diagnosing physician had never heard of it but found it by googling Thisbe's symptoms. Eventually, we found one doctor who had seen a case like hers - 30 years earlier.
The medical term is progressive bulbar palsy (PBP), which is not a specific disease but more like a constellation of symptoms. These include the loss of swallowing, breathing, speaking, communicating, seeing, laughing, smiling, and eating. When this syndrome also involves hearing loss, it has been named Brown-Vialetto-Van Laere (BVVL). In Thisbe's case, BVVL began by paralyzing her vocal cords, and it kept on taking until there was nothing left - except her mind. As if this disease were not torture enough for a small child, it spared her mind so that she also cognitively suffered the ravaging of her little body.
It began on Thanksgiving Day of 2005, with something seemingly as simple as a wheeze. But within five weeks, we learned it was by no means something simple. Her vocal cords were paralyzed in a near-closed position, and she was having a hard time breathing. The motor neurons that controlled the muscles for speaking and breathing had been dying over the course of that month. As more neurons died, the muscles received less and less stimulation to move, and eventually, they just stopped moving altogether. The only way to keep her from suffocating was to give her a tracheostomy: a tube in her neck that connected her lungs to the outside air that she breathed. Due to this unnatural mechanism for breathing, she developed repeated pneumonias and tiny "plugs" of mucus in the tube over time. These plugs repeatedly cut off her airway, sometimes as often as several times a day. In essence, each time she "plugged up" she was suffocating again and again - over and over, and we would rush to try to open her airway through the emergency procedures we'd learned in the hospital and from others we'd learned "in the field." 
Eventually, because of a slow descending paralysis, Thisbe lost her ability to walk, hold up her neck, pick up her arms, move her fingers, and so much more. We felt as if we were watching our daughter being buried alive in her own skin. Her mind was perfect. She knew what was happening to her, but she couldn't understand why. In the beginning, she learned to communicate using sign language, but as she began to lose her arm, hand, and finger function, this became more and more difficult. And like any two-year-old, she would get frustrated. After all, she had swapped her beautiful, healthy life for a life where machines kept her alive and connected to a wall.
On Thanksgiving Day of 2006, exactly one year after her symptoms began, Thisbe developed a mucus plug that suffocated her...to death. She died in our arms, only to be resurrected by our crude emergency procedures and brought back to her hell to survive another five months. On April 30, 2007, Thisbe died. She was two months shy of her 3rd birthday. Our little Thisbe could fight no longer.
She was our baby girl; our paci juggler; our daddy's girl; the "busy bee"; the "wild" one; the gigantic smile; the lover of time outs, blueberries and tofu dogs, bath time, reading books, We're Going on a Bear Hunt, Signing Time with Alex and Leah, Baby Einstein on planes, being the expert at animal signs, the "all done," "Daddy," and "book" signs, going to the zoo, feeding the ducks, exploring for "treasures," digging in wallets and purses, playing games and doing puzzles, pushing the doll stroller, making castles in the sand, riding in the red plastic car, making Panga eat bubbles; The Sparkle in Our Eyes, and she was gone.
One month after Thisbe's death, the other unimaginable happened. Our son, Noah, just ten-months-old at the time, began showing one of the initial symptoms of the same disease: a droopy eyelid. In Noah's short life, despite his seemingly good health up to that point, he had endured open-heart surgery when he was just three-days-old to repair a congenital heart defect called Transposition of the Great Arteries (TGA). We found out about this condition when I was six months pregnant. The doctor told us we should abort him, due to everything we had going on with Thisbe and with other possible complications that may be undetected. But he was our son, and we wanted to keep him. We decided to take a leap of faith. After all, in our world a congenital heart defect was easy. We were actually grateful for it because there had never been a recorded case of BVVL with a congenital heart defect. To us, that meant he was in the clear as far as BVVL was concerned. BVVL was a beast no one wanted to face, but TGA we could do, and we could do it without a hint of fear. Noah was going to be our salvation - a sign from God that the waters would recede, that Thisbe would get better, and this nightmare would be behind us. Noah was our final hope for a miracle.
When Noah was born the doctors found that he had no other congenital anomalies, just "straight-up TGA." We delivered him at Stanford so that the best TGA surgeon in the world could repair his heart. When he came out of surgery, they said it was one of the smoothest repairs ever. Then, Noah surprised the entire surgical staff by soaring through his recovery and being released just eight days later. They called him the "Little Superman." He was our healing miracle, our little "Manny," and we felt that he was here to give his sister the push and inspiration she needed to get well. It was all supposed to get better from there. Or so we thought.
So much for all of our hopes and dreams for miracles unceasing. When we returned to Phoenix, Thisbe progressed into the depths of the disease. Within two months we had to face the reality that we may actually lose our fight - that she may actually be taken from us. And she was. But that wasn't to be the end of our horror. When he was ten-months-old Noah's eyelid began to droop. Doctors said it had to be a coincidence - that maybe during his TGA repair a nerve was slightly damaged. And that's what we chose to believe, that it was all just the blackest of all jokes. None of us would believe that he, too, would succumb to BVVL. We were all wrong. Two months after seeing his droopy eyelid, I took him in for a hearing test. He had passed the previous one, as well as all of the other tests for motor neuron involvement, but I couldn't stop thinking that he seemed to not hear me some of the time. I wanted to prove that it was all in my head. I was convinced that my overwhelming grief and suffering over the death of Thisbe was causing me to be paranoid. I was devastatingly wrong. The second test confirmed hearing loss. Most parents who get a concerning hearing test result don't suffer and despair as though it is a death sentence. But for us, it was.
 Two weeks later, Noah's vocal cords were paralyzed, although in a slightly more open position than Thisbe's had been. Within five months, our son had lost all facial expression, and his walking became clumsy. His hand grasp was weakening, but he could still shoot hoops with the big boys. We had no idea how close we were to losing him. I had to hold onto a semblance of hope to be able to get up and face each day without my daughter, and now with the crushing thoughts of the death of my son, too. My lifeline: his TGA. "He had been born different, so his disease path may be different." I held tightly to this thought. His TGA became my hope that maybe somehow in his embryonic development this anomaly of TGA with BVVL just may have thrown off the inevitable destruction that typically occurs. Again, we had hope, and we pressed on.
We continued to search for treatments that we hadn't been able to give Thisbe, and when they seemed to be failing we moved on to another path: finding the gene responsible for BVVL. During our final attempts at finding another treatment, we were told that if we found the gene we would find help. My last hope was that he could hold on long enough for us to find that help. Nine months after the onset of his disease, on April 9, 2008, Noah died. He was five months shy of his 2nd birthday.
He was our baby boy; our little superman; our "Manny"; our mama's boy; the sweet and patient one; the little chef, pro-burger-flipper; the computer whiz; our lover of drums, pacis, bath time, sage sausage, T-bone the dragon, music class, the Johnny Jump Up, Barnyard Dance, Rihanna and Fergie, all things related to tractors and steering wheels, balls of every type and size, basketball, tee ball and soccer, Baby Signing Time, swinging in the best of all swings, the "more" and "hat" sign, riding in the red plastic car, making Sherpa fetch the ball; The Beat of Our Hearts, and he was gone.
Just like his sister, Noah died in our arms. He fought, just like his sister. In the end he fought for every breath - for one long hour, every few minutes we thought he'd gone, but he took another horrible gasp. And even after all the oxygen in his body had run out, his strong little repaired heart was still beating - barely - just barely - until he was gone. We buried our son exactly three weeks before the year-mark of Thisbe's funeral.
It is the mission of the Thisbe and Noah Scott Foundation to save lives by promoting research, awareness and support for children and families affected by pediatric neuromuscular diseases. As Thisbe and Noah's parents, we can think of no better way to honor their lives than to assure that a neuromuscular disease will never again take the life or health of another child.
|
|
BVVL International is a project of the Thisbe and Noah Scott Foundation. Created in June 2008, it is the first web-based resource tool for physicians, researchers, and families interested in learning more about Brown-Vialetto-Van Laere syndrome. BVVL International is a resource for anyone interested in learning more about the disease and includes the following:
- Summary information from case reports of individuals with BVVL in the medical literature
- Current research underway towards finding other potential genetic mechanisms responsible for the disease
- A way to connect with others involved in similar research so that they can share ideas and hasten their progress towards
curing pediatric neuromuscular diseases - How to get involved in advocacy efforts to increase research and funding for BVVL and other rare genetic diseases
- Opportunities to contribute monetarily to ongoing research on BVVL and other pediatric neuromuscular disease
BVVL International Patient and Family Resources
Connect with other BVVL and Fazio-Londe families:
SMASpace is an online connection tool with a BVVL Group. Go to www.smaspace.com, become a member, and click on "Groups." If the "BVVL/Fazio Londe" Group doesn't show up immediately, then click on "Show All." Join that group and begin a discussion with another parent going through something similar. Or, become friends with other SMA families, as everyone on this site is looking to connect with other people whose children are suffering through motor neuron diseases. www.smaspace.com Regain the Ability to Communicate with your Child:
The Thisbe and Noah Scott Foundation outreach is loaning out iPads with a specially designed App to help children with neuromuscular diseases regain their "voices." As degeneration progresses, so does a child's ability to communicate. Contact the Executive Director, Lindsay Ballew, for more information on this program: lballew@thisbeandnoah.org. Read Articles in the BVVL Patient Library:
BVVL International has a collection of published articles on BVVL and Fazio Londe. Most of these are only available through online purchase or through a subscription to the publication journal; however, researchers have been kind enough to provide our organization with these articles to offer as resources to patients and their families.
Other Resources: For further information and instruction on the informal study of Riboflavin therapy, please contact one of the authors, Dr. Bosch, at the University of Amsterdam at a.m.bosch@amc.nl.
For BVVL genetic testing on C20orf54, please visit http://www.ncbi.nlm.nih.gov/sites/GeneTests/?db=GeneTests, under BVVLS, where the details of the lab and services they offer can be found.The Motor Neuron Center is the first initiative of the Columbia University Center for Neurosciences Initiative (CNI) in New York, dedicated to bringing researchers together to find the mechanisms responsible for pediatric and adult motor neuron diseases. www.columbiamnc.org
The Office of Rare Diseases (ORD) at the National Institutes of Health (NIH) provides information about rare diseases to health care professionals, patients and families, and helps to coordinate research.
http://rarediseases.info.nih.gov/ The Genetic and Rare Diseases Information Center (GARD) provides information for the general public, including patients and their families, health care professionals and biomedical researchers. It was established by the National Human Genome Research Institute (NHGRI) and the Office of Rare Diseases (ORD). www.genome.gov/10000409
The Scott family founded ETS Publishing, which published its first children's picture book, Thisbe's Promise, in the fall of 2008, to honor their daughter, Thisbe, as well as to provide a resource for parents and children struggling for hope and promise in the midst of a profound illness. www.etspublishinghouse.com Genetic Alliance provides a comprehensive rare disease database and list of relevant associations/organizations for patients and their families, as well as advocacy tools to promote research for genetic diseases. www.geneticalliance.org
|
Child Neurology Heroes Dinner
Saturday, November 8th, 2014
Four Seasons Hotel, Beverly Hills, CA
300 South Doheny Drive, Los Angeles, CA 90048
6:00pm Reception & Silent Auction 7:00pm Dinner & Program
Cocktail Attire
RSVP 310-491-1401
|
HERO OF HONOR ($25,000)
* Two tables of 10 at the event (most preferred seating)
* Full page spread in the Hero of Honoe section of the
Tribute Journal
* Logo included on stage screen and Step & Repeat backdrop
* Prominent listing as a Hero of Honor in all printed materials,
whenever possible (if received before the print deadline)
|
HERO OF VALOR ($15,000)
* One tables of 10 at the event (more preferred seating)
* Full page Tribute in the Hero of Valor section of the Tribute Journal
* Logo included on stage screen and Step & Repeat backdrop
* Prominent listing as a Hero of Valor in all printed materials,
whenever possible (if received before the print deadline)
| |
HERO OF GLORY ($7,500)
* One tables of 10 at the event (preferred seating)
* Full page Tribute in the Hero of Glory section of the
Tribute Journal
* Logo included on stage screen
* Prominent listing as a Hero of Glory in all printed materials,
whenever possible (if received before the print deadline)
|
HERO OF INSPIRATION ($5,000)
* One tables of 10 at the event (preferred seating)
* Full page Tribute in the Hero of Inspiration section of the Tribute Journal
* Prominent listing as a Hero of Inspiration in all printed materials, whenever possible (if received before the print deadline)
| HERO TABLE ($2,500)
One table of 10 at the event
|
HERO TICKET ($250)
I/we would like to purchase _______ Hero Ticket(s) at $250/ticket
|
Tribute Journal
|
Inside Cover (front or back): $2,500
|
Half Page Tribute: $500
| Full Page Tribute: $1,000
|
Quarter Page Tribute: $250
|
HERO:
hero (masculine) or heroine (feminine)
(Ancient Greek: ἥρως, hḗrōs) refers to characters who, in the face of danger and adversity or from a position of weakness, display courage and the will for self-sacrifice-that is, heroism-for some greater good of all humanity.
FROM WIKIPEDIA, THE FREE ENCYCLOPEDIA
|
ABOUT CNF
Established in 2001, the Child Neurology Foundation (CNF) 501c(3) is a national nonprofit organization that works through advocacy, research, and educational initiatives to ensure optimal care for all children living with a neurologic disease. CNF'S Mission In Action is to advocate for children and adolescents with neurologic disorders, fund research awards that advance treatments and cures for pediatric neurologic diseases, advocate for the recruitment of physicians in the field of child neurology, and provide families and caregivers with the educational information and resources necessary to access quality health care. http://www.childneurologyfoundation.org/
|
|
|
|
|
Child Neurology Foundation
| 201 Chicago Avenue #200|Minneapolis, MN 55415 |
Copyright © 2014. All Rights Reserved.
|
|
|
|
|
|
|
|